Revisiting the Ghrelin Changes Following Bariatric and Metabolic Surgery.

Bariatric/metabolic surgery Comorbidity resolution Diet-induced obesity Ghrelin

Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 24 4 2020
medline: 15 4 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

Since the description of ghrelin in 1999, several studies have dug into the effects of this hormone and its relationship with bariatric surgery. While some aspects are still unresolved, a clear connection between ghrelin and the changes after metabolic surgery have been established. Besides weight loss, a significant amelioration in obesity-related comorbidities following surgery has also been reported. These changes in patients occur in the early postoperative period, before the weight loss appears, so that amelioration may be mainly due to hormonal changes. The purpose of this review is to go through the current body of knowledge of ghrelin's physiology, as well as to update and clarify the changes that take place in ghrelin concentrations following bariatric/metabolic surgery together with their potential consolidation to outcomes.

Identifiants

pubmed: 32323063
doi: 10.1007/s11695-020-04601-5
pii: 10.1007/s11695-020-04601-5
doi:

Substances chimiques

Ghrelin 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2763-2780

Auteurs

Carlota Tuero (C)

Obesity Area, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain. ctuero@unav.es.
Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain. ctuero@unav.es.

Victor Valenti (V)

Obesity Area, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
CIBEROBN, Instituto de Salud Carlos III, Pamplona, Navarra, Spain.
Obesity and Adipobiology Group, IdiSNA, Pamplona, Spain.

Fernando Rotellar (F)

Obesity Area, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
CIBEROBN, Instituto de Salud Carlos III, Pamplona, Navarra, Spain.
Obesity and Adipobiology Group, IdiSNA, Pamplona, Spain.

Manuel F Landecho (MF)

Obesity Area, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
Department of Internal Medicine, General Health Check-up unit, Clínica Universidad de Navarra, Pamplona, Spain.

Javier A Cienfuegos (JA)

Obesity Area, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain.
Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
CIBEROBN, Instituto de Salud Carlos III, Pamplona, Navarra, Spain.
Obesity and Adipobiology Group, IdiSNA, Pamplona, Spain.

Gema Frühbeck (G)

Obesity Area, Clínica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Navarra, Spain. gfruhbeck@unav.es.
CIBEROBN, Instituto de Salud Carlos III, Pamplona, Navarra, Spain. gfruhbeck@unav.es.
Obesity and Adipobiology Group, IdiSNA, Pamplona, Spain. gfruhbeck@unav.es.
Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain. gfruhbeck@unav.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH